HOME › DRUGS › LAROTRECTINIB
ACTIVE SUBSTANCE / INN

LAROTRECTINIB

Brand name(s): Vitrakvi
EMA LISTED
AUTHORISED
Abdominal Neoplasms
ACTIVE SUBSTANCE
Larotrectinib
REGULATORS
EMA
SPONSORS / MAH
Bayer AG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VitrakviBayer AGAuthorised19/09/2019Abdominal Neoplasms

FULL INTELLIGENCE ON LAROTRECTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →